["{\n\"step_by_step_thinking\": \"Firstly, we need to identify if there's any mention of deletion at 6q24.2-26 being associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs) in the provided documents. Upon reviewing the articles, we see that Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers mentions the frequent losses observed between loci defined by CI6-119 (D6S195) at 6q26 and CI6-49 (D6S161) at 6q27, which suggests a commonly deleted region between loci defined by CI6-111 (D6S193) and CI6-24 (D6S149). This region is estimated to be approximately 1.9 cM apart on the basis of linkage analysis.\n\nIn Allelotype of human ovarian cancer, it's mentioned that frequent losses were observed uniquely in serous and serous papillary cystadenocarcinomas on chromosomes 6q, 13q, and 19q. This suggests that there might be a correlation between deletion at 6q24-26 and high-grade serous ovarian carcinoma.\n\nHowever, we don't find any direct evidence supporting the association of deletion at 6q24.2-26 with longer survival in patients with HGSOCs. Therefore, our answer will rely on the information provided.\",\n\"answer_choice\": \"B: no\""]